The Children’s Research Institute Seminar Series: “Epigenetic Modulation of the Cancer Antigen GD2 to Improve Immunotherapy in Pediatric Solid Tumors”

Justin Sperlazza is a pediatric oncologist working on understanding how chromatin-directed therapeutics can influence tumor susceptibility to immunotherapy, particularly CAR-T therapy, in Ewing’s Sarcoma.

Please contact childrensresearch@med.unc.edu for Zoom details.

In person, 3116 Mary Ellen Jones & Zoom option.

Children’s Research Institute
919-962-3424

childrensresearch@med.unc.edu